Archives
-
Methylprednisolone Sodium Succinate Guide
2026-09-18
A practical, scenario-based guide to using Methylprednisolone Sodium Succinate (SKU B4953) in viability, proliferation, cytotoxicity, ROS, and immunology workflows. It covers concentration selection, assay controls, interpretation, formulation, and vendor reliability using product-specific quantitative data.
-
Mouse Neutrophil Cell Isolation Kit Workflow
2026-09-17
Build a rapid, column-free workflow for obtaining highly pure mouse neutrophils from bone marrow, blood, or spleen while minimizing direct target-cell labeling. The approach is particularly useful for activation-sensitive assays, co-culture, and mechanistic testing of neutrophil-targeted mRNA nanovaccines.
-
GSK J4 HCl: JMJD3 Workflows for Chromatin Studies
2026-09-17
GSK J4 HCl enables mechanism-first studies linking H3K27 demethylation to cytokine control, decidual immune signaling, and K27M glioma biology. This practical guide combines assay design, dose logic, chromatin readouts, and troubleshooting for more interpretable JMJD3 inhibitor experiments.
-
ERADECs: ERAD-Based Degradation of TM Proteins
2026-09-16
Song and colleagues introduce ERAD-engaging chimeras (ERADECs), a small-molecule strategy that redirects the endoplasmic reticulum quality-control pathway toward transmembrane protein degradation. The study links desonide to the ER E3 ligase SYVN1 and demonstrates efficient PD-L1 depletion, tumor suppression, and degradation of mutant HTT, while defining important requirements for translating the platform.
-
Liproxstatin-1: Ferroptosis Inhibitor Workflow
2026-09-16
Liproxstatin-1 helps distinguish lipid peroxidation-driven cell death from apoptosis and nonspecific oxidative injury. This practical workflow connects GPX4-deficient cell protection with the sex-specific salivary gland findings reported in a 2025 reference study, while emphasizing controls, dosing, and interpretation.
-
HNRNPU K181 Lactylation Rewires Cervical Cancer Metabolism
2026-09-15
This Advanced Science study identifies HNRNPU lysine 181 lactylation as a non-histone mechanism connecting lactate accumulation with PHGDH expression, serine biosynthesis, and cervical cancer growth. Its integrated molecular and in vivo evidence also suggests that a lactylation–acetylation switch may be therapeutically relevant, while highlighting the need for orthogonal controls in mechanistic experiments.
-
(S)-Mephenytoin in Human Intestinal Organoids
2026-09-15
Human iPSC-derived intestinal organoids are moving pharmacokinetic research beyond legacy animal and cancer-cell models. This article examines how (S)-Mephenytoin, a mechanistically defined CYP2C19 substrate, can serve as a translational probe for validating intestinal oxidative drug metabolism while highlighting assay design, model limitations, and strategic next steps.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-09-14
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic program triggered by loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional failure alone. Their functional-genomics and chemogenetic analyses define the Pol II degradation-dependent apoptotic response and suggest a framework for reassessing how diverse anticancer drugs induce cell death.
-
L-Alanyl-L-Glutamine: Practical Workflow Guide
2026-09-14
L-Alanyl-L-Glutamine provides a water-soluble L-Ala-L-Gln dipeptide format for gastrointestinal, nutrient-support, and intestinal barrier research workflows. It is suitable for freshly prepared aqueous applications, but not for DMSO or ethanol systems or experiments requiring long-term storage of aqueous solutions.
-
Sabutoclax Workflow for Pan-Bcl-2 Apoptosis Assays
2026-09-13
Sabutoclax is a cell-permeable pan-Bcl-2 inhibitor suited to mechanism-focused apoptosis studies, dose-response profiling, and translational cancer models. A workflow that separates growth arrest from true cell killing improves interpretation across prostate, lung, and B-cell malignancy systems.
-
Dual-Action p38α Inhibitors and Dephosphorylation
2026-09-12
The reference preprint shows that selected kinase inhibitors can both block p38α activity and accelerate WIP1-mediated removal of its activation-loop phosphate. Structural and biochemical evidence links this effect to an inhibitor-stabilized activation-loop conformation, offering a mechanistic framework for improving kinase inhibitor potency and selectivity.
-
QNZ (EVP4593) NF-κB Workflow Guide
2026-09-11
QNZ (EVP4593) enables nanomolar interrogation of NF-κB signaling in reporter, inflammatory, and Huntington’s disease research workflows. This guide connects dose planning, orthogonal readouts, formulation control, and troubleshooting to improve reproducibility without confusing pathway inhibition with antibacterial activity.
-
GSK 2837808A: Selective LDHA Inhibitor Guide
2026-09-11
GSK 2837808A is a potent lactate dehydrogenase A inhibitor that reports nanomolar inhibition of LDHA and weaker inhibition of LDHB. Its rapid clearance and limited oral exposure make it most suitable for controlled in vitro cancer metabolism research rather than direct therapeutic interpretation.
-
PPZ1-TORC1 Signaling Drives Fungal Ferroptosis
2026-09-10
The reference study identifies a PPZ1-TORC1 regulatory axis that controls t-BuOOH-induced ferroptosis, autophagy, and antifungal resistance in Candida albicans. Its findings position ferroptosis as a potential antifungal strategy while highlighting important limits when translating mammalian ferroptosis workflows to fungi.
-
G-1 and the Translational Logic of GPR30
2026-09-10
G-1 enables selective interrogation of GPR30 signaling across pain, cardiac, and cancer models, while highlighting the experimental controls needed to translate receptor biology into robust disease insight.